PT2364711T - Utilização de extratos de pele de coelho inflamada pelo vírus vaccinia para o fabrico de um medicamento para o tratamento da doença cerebrovascular aguda - Google Patents

Utilização de extratos de pele de coelho inflamada pelo vírus vaccinia para o fabrico de um medicamento para o tratamento da doença cerebrovascular aguda

Info

Publication number
PT2364711T
PT2364711T PT98257066T PT09825706T PT2364711T PT 2364711 T PT2364711 T PT 2364711T PT 98257066 T PT98257066 T PT 98257066T PT 09825706 T PT09825706 T PT 09825706T PT 2364711 T PT2364711 T PT 2364711T
Authority
PT
Portugal
Prior art keywords
medicament
extracts
manufacture
treatment
vaccinia virus
Prior art date
Application number
PT98257066T
Other languages
English (en)
Inventor
Sang James Lau Man
Original Assignee
Vanworld Pharmaceutical (Rugao) Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42169603&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2364711(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vanworld Pharmaceutical (Rugao) Co Ltd filed Critical Vanworld Pharmaceutical (Rugao) Co Ltd
Publication of PT2364711T publication Critical patent/PT2364711T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT98257066T 2008-11-11 2009-10-23 Utilização de extratos de pele de coelho inflamada pelo vírus vaccinia para o fabrico de um medicamento para o tratamento da doença cerebrovascular aguda PT2364711T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200810176703.4A CN101732348B (zh) 2008-11-11 2008-11-11 牛痘疫苗致炎兔皮提取物在制备急性脑血管疾病治疗药物中的用途

Publications (1)

Publication Number Publication Date
PT2364711T true PT2364711T (pt) 2017-01-18

Family

ID=42169603

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98257066T PT2364711T (pt) 2008-11-11 2009-10-23 Utilização de extratos de pele de coelho inflamada pelo vírus vaccinia para o fabrico de um medicamento para o tratamento da doença cerebrovascular aguda

Country Status (20)

Country Link
US (1) US10265345B2 (pt)
EP (1) EP2364711B2 (pt)
JP (3) JP6085806B2 (pt)
KR (1) KR101756201B1 (pt)
CN (1) CN101732348B (pt)
AU (1) AU2009316168B2 (pt)
CA (1) CA2743090C (pt)
CY (1) CY1118457T1 (pt)
DK (1) DK2364711T3 (pt)
ES (1) ES2606051T5 (pt)
HK (1) HK1142546A1 (pt)
HR (1) HRP20161716T1 (pt)
HU (1) HUE030782T2 (pt)
LT (1) LT2364711T (pt)
NZ (1) NZ592696A (pt)
PL (1) PL2364711T3 (pt)
PT (1) PT2364711T (pt)
SI (1) SI2364711T1 (pt)
SM (1) SMT201600477B (pt)
WO (1) WO2010054531A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101732348B (zh) * 2008-11-11 2015-01-14 威世药业(如皋)有限公司 牛痘疫苗致炎兔皮提取物在制备急性脑血管疾病治疗药物中的用途
KR20190121782A (ko) * 2017-03-06 2019-10-28 준 리우 Aβ-유발 손상에 대한 억제 또는 경감제
CN109504649B (zh) * 2017-09-15 2022-06-14 天津小西生物医药科技有限公司 使用兔皮提取物促进细胞增殖的方法
KR20200103647A (ko) * 2017-12-28 2020-09-02 가꼬우호우징 효고 이카다이가쿠 리포칼린형 프로스타글란딘 d2 합성 효소 산생 촉진제
WO2020024142A1 (en) * 2018-08-01 2020-02-06 Vanford Bio-Drug Development Limited Novel peptides and its derivatives capable of stimulating cytokine release
US20220202873A1 (en) 2019-04-17 2022-06-30 Nexus Bio-Drug Development Limited Use of extract from rabbit skin inflamed by vaccinia virus in treating hematopoietic system damage
US20220354900A1 (en) 2019-06-14 2022-11-10 Mega Winning Limited Use of extract from rabbit skin inflamed by vaccinia virus in treatment of cancer
CN110693914A (zh) * 2019-10-28 2020-01-17 威世药业(如皋)有限公司 痘苗病毒致炎兔皮提取物在治疗类风湿性关节中的应用
WO2023184471A1 (zh) * 2022-04-01 2023-10-05 星亮生物技术有限公司 痘苗病毒致炎兔皮提取物治疗帕金森病的用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4985254A (en) * 1987-11-06 1991-01-15 Nippon Zoki Pharmaceutical Co., Ltd. Method of treating ischemic diseases
JP2539665B2 (ja) * 1988-06-20 1996-10-02 日本臓器製薬株式会社 神経疾患治療剤
JP2732379B2 (ja) * 1995-12-18 1998-03-30 日本臓器製薬株式会社 知覚異常改善剤
US6197806B1 (en) 1995-12-20 2001-03-06 Nippon Zoki Pharmaceutical Co., Ltd. Eliminating agent for activated oxygen and free radicals
CA2266640C (en) * 1996-09-27 2011-05-24 The Trustees Of Columbia University In The City Of New York Methods for treating an ischemic disorder and improving stroke outcome
JP4033936B2 (ja) * 1997-01-08 2008-01-16 日本臓器製薬株式会社 一酸化窒素産生抑制剤
KR19990083516A (ko) 1998-04-27 1999-11-25 고니시 진우에몬 허혈성질환치료제
JP2000016942A (ja) 1998-04-27 2000-01-18 Nippon Zoki Pharmaceut Co Ltd 虚血性疾患治療剤
CN1055249C (zh) * 1998-07-15 2000-08-09 沈继平 一种镇痛药和其制造方法
JP2000143536A (ja) 1998-11-13 2000-05-23 Nippon Zoki Pharmaceut Co Ltd 抗浮腫剤
JP2001058949A (ja) 1999-08-20 2001-03-06 Fujimoto Brothers:Kk 抗ショック剤
JP4612924B2 (ja) 1999-08-20 2011-01-12 藤本製薬株式会社 サイトカイン調節剤
CN1207005C (zh) 2002-10-31 2005-06-22 威世药业(如皋)有限公司 含生物活性物质的兔皮和其用途
JP3818657B2 (ja) 2004-12-01 2006-09-06 日本臓器製薬株式会社 乾燥物及びその製造方法
KR101307999B1 (ko) * 2004-12-01 2013-09-12 니폰 조키 세야쿠 가부시키가이샤 건조물 및 그 제조방법
AU2006332713B2 (en) * 2005-12-30 2013-01-17 Takeda Pharmaceutical Company Limited Metalloproteinase binding proteins
TWI406664B (zh) 2006-03-30 2013-09-01 Univ Kyoto 硫氧還蛋白(thioredoxin)產生促進劑
CN101732348B (zh) * 2008-11-11 2015-01-14 威世药业(如皋)有限公司 牛痘疫苗致炎兔皮提取物在制备急性脑血管疾病治疗药物中的用途

Also Published As

Publication number Publication date
ES2606051T5 (es) 2020-05-14
JP2017052788A (ja) 2017-03-16
EP2364711A1 (en) 2011-09-14
AU2009316168A1 (en) 2010-05-20
CN101732348B (zh) 2015-01-14
EP2364711B1 (en) 2016-10-12
HUE030782T2 (en) 2017-06-28
EP2364711B2 (en) 2019-10-30
SMT201600477B (it) 2017-03-08
JP2015028076A (ja) 2015-02-12
CY1118457T1 (el) 2017-07-12
HRP20161716T1 (hr) 2017-02-10
KR20110086136A (ko) 2011-07-27
CA2743090C (en) 2021-04-27
ES2606051T3 (es) 2017-03-17
SI2364711T1 (sl) 2017-05-31
JP2012508192A (ja) 2012-04-05
JP6085806B2 (ja) 2017-03-01
HK1142546A1 (en) 2010-12-10
CA2743090A1 (en) 2010-05-20
NZ592696A (en) 2013-02-22
EP2364711A4 (en) 2012-12-12
WO2010054531A1 (zh) 2010-05-20
US10265345B2 (en) 2019-04-23
US20110268814A1 (en) 2011-11-03
DK2364711T3 (en) 2017-01-30
AU2009316168B2 (en) 2015-03-12
PL2364711T3 (pl) 2017-07-31
LT2364711T (lt) 2017-03-10
CN101732348A (zh) 2010-06-16
KR101756201B1 (ko) 2017-07-10

Similar Documents

Publication Publication Date Title
HK1142546A1 (en) Use of extracts from rabbit skin inflamed by vaccinia virus for the manufacture of a medicament for the treatment of acute cerebrovascular disease
BRPI0917567A2 (pt) tratamento de doença respiratória
BRPI1012116A2 (pt) composição farmacêutica para o tratamento de doenças cardíacas
BRPI0906467A2 (pt) forma de dose farmacêutica
IL217901B (en) Use of laquinimod or a laquinimod salt in the manufacture of a drug for the treatment of bdnf-related diseases
BRPI0819630A2 (pt) Montagem de interface de paciente para terapia respiratória
DK2488242T3 (da) Medicinsk indåndingsmaske
ZA201403549B (en) Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation
DK2627345T3 (da) Formuleringer til behandling af sygdomme i de øvre luftveje
GB0906159D0 (en) Drug combination for the treatment of proteostatic diseases
DE102009018133A8 (de) Pharmazeutische Zusammensetzung zur Behandlung von dermatologischen Autoimmunerkrankungen
DK2379066T3 (da) Anvendelse af opioidantagonister til fremstilling af et lægemiddel til behandling af retinadegenerationssygdomme
IL213606A0 (en) 1-amino-alkylcyclohexane derivatives for the treatment of inflamatory skin diseases
IL216717A (en) Use of benzidamine in the manufacture of a drug for the treatment of p40-dependent diseases
DK2344166T3 (da) Farmaceutisk præparat til behandlingen af gastrointestinale irritationslidelser
IT1402712B1 (it) Unita' per l'esecuzione di trattamenti estetici, cosmetici e terapeutici.
ES1067182Y (es) "maletin de asistencia medica"
TH0801000702A (th) อะคลิดิเนียมสำหรับใช้โดยการสูดในการบำบัดโรคทางเดินหายใจ
TH0901000513A (th) อนุพันธ์สไปโรไซคลิค แอมีดสำหรับการรักษาโรคปอด
GB0801511D0 (en) The treatment of ophthalmic diseases
GB0823568D0 (en) Respiratory disease treatment
GB0814488D0 (en) Respiratory disease treatment
ES1071962Y (es) Parche fisico potenciador de la respiracion nasal
BR112013023187A2 (pt) regimes de dosagem para o tratamento da doença de fabry
GB201018325D0 (en) Treatment for dupuytren's disease